From the FDA Drug Label
Information for Patients Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly The use of Adderall, which contains amphetamine, may be disqualifying for a DOT (Department of Transportation) certification due to its potential to impair the ability to operate vehicles. 1
From the Research
Adderall can be disqualifying for DOT medical certification, but it depends on individual circumstances, and the most recent evidence suggests that careful evaluation is necessary due to potential cardiovascular risks 2. The Federal Motor Carrier Safety Administration (FMCSA) does not automatically disqualify drivers who take Adderall (amphetamine/dextroamphetamine), but it requires careful evaluation.
- Drivers who use Adderall must obtain a letter from their prescribing physician stating that the medication is necessary, the condition is stable, and the medication doesn't impair driving ability.
- The DOT medical examiner will then make a case-by-case determination.
- Typically, the examiner will want documentation that you've been on a stable dose for at least 30 days with no significant side effects. The concern with Adderall is that it's a Schedule II controlled substance that can cause side effects like insomnia, nervousness, and cardiovascular issues that could affect safe driving, as supported by a recent study that found amphetamines increase blood pressure and heart rate 2. If you're prescribed Adderall, you should gather documentation from your healthcare provider before your DOT physical and be prepared to discuss your treatment history, medication dosage, and any side effects you experience. Some drivers may need to complete additional testing or monitoring to maintain certification while on this medication, especially considering the potential for misuse and prescription stimulant use disorder (PSUD) associated with amphetamine use 3. It's essential to prioritize careful evaluation and monitoring to ensure safe driving practices, given the potential risks associated with Adderall use, as highlighted by recent studies 2, 3.